Literature DB >> 4030280

Use of oxygen driven nebulizer delivery systems for beta-2 agonists in chronic bronchitis.

D O'Donnell, C P Kelly, P Cotter, L Clancy.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1985        PMID： 4030280     DOI： 10.1007/bf02937361

Source DB:  PubMed          Journal:  Ir J Med Sci        ISSN： 0021-1265            Impact factor:   1.568


× No keyword cloud information.
  7 in total

1.  Carbon dioxide narcosis in emphysema.

Authors:  E K WESTLAKE; T SIMPSON; M KAYE
Journal:  Q J Med       Date:  1955-04

2.  Comparison of effect of salbutamol and isoprenaline on spirometry and blood-gas tensions in bronchial asthma.

Authors:  K N Palmer; J S Legge; W F Hamilton; M L Diament
Journal:  Br Med J       Date:  1970-04-04

3.  The effect of a new sympathomimetic beta-receptor stimulating drug (terbutaline) on arterial blood gases in bronchial sthma.

Authors:  J DaCosta; U Hedstrand
Journal:  Scand J Respir Dis       Date:  1970

4.  Assessment of jet nebulisers for lung aerosol therapy.

Authors:  M M Clay; D Pavia; S P Newman; T Lennard-Jones; S W Clarke
Journal:  Lancet       Date:  1983-09-10       Impact factor: 79.321

5.  The effects of nebulized salbutamol on lung function and exercise tolerance in patients with severe airflow obstruction.

Authors:  S J Connellan; S E Gough
Journal:  Br J Dis Chest       Date:  1982-04

6.  Oxygen as a driving gas for nebulisers: safe or dangerous?

Authors:  K A Gunawardena; B Patel; I A Campbell; J B MacDonald; A P Smith
Journal:  Br Med J (Clin Res Ed)       Date:  1984-01-28

7.  Domiciliary nebulised salbutamol solution in severe chronic airway obstruction.

Authors:  R S Wilson; S J Connellan
Journal:  Thorax       Date:  1980-11       Impact factor: 9.139
  7 in total
  1 in total

1.  Oxygen versus air-driven nebulisers for exacerbations of chronic obstructive pulmonary disease: a randomised controlled trial.

Authors:  George Bardsley; Janine Pilcher; Steven McKinstry; Philippa Shirtcliffe; James Berry; James Fingleton; Mark Weatherall; Richard Beasley
Journal:  BMC Pulm Med       Date:  2018-10-03       Impact factor: 3.317
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.